Skip to Main content Skip to Navigation
Journal articles

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?

Abstract : Insights into antitumor T-cell responses may help the development of more efficient treatments for lung cancer. The interplay between preexisting antitumor CD4(+) T-cell responses and platinum-based chemotherapy is crucial to improve patient survival. Accumulating evidence confirms that selecting cancer patients in whom chemotherapy can activate an anticancer immune response would largely improve the success of novel therapeutic approaches.
Document type :
Journal articles
Complete list of metadatas

Cited literature [10 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00826885
Contributor : Philippe Saas <>
Submitted on : Thursday, May 30, 2013 - 4:40:53 PM
Last modification on : Wednesday, September 16, 2020 - 10:43:29 AM
Long-term archiving on: : Tuesday, September 3, 2013 - 9:52:45 AM

File

23_2012ONCOIMM0238.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Yann Godet, Magalie Dosset, Christophe Borg, Olivier Adotevi. Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?. OncoImmunology, Taylor & Francis, 2012, 1 (9), pp.1617-1619. ⟨10.4161/onci.21513⟩. ⟨inserm-00826885⟩

Share

Metrics

Record views

391

Files downloads

431